Cancer Research Technology
Log in Register
Menu

Anti-C170 [NCRC22]

Invented by Prof Lindy Durrant at University of Nottingham

Info

Catalogue Number 152937
Applications ELISA FACS
Antigen/Gene or Protein Targets C170 - Colorectal carcinoma cell line
Reactivity Human
Relevance Colorectal carcinoma is one of the most common malignant neoplasms. The cell line C170 was derived directly from a human primary tumor and as such was used as an immunogen to generate an antibody which is able to detect an epitope of a variety of colorectal cancerous cell lines.
Host Mouse
Immunogen C170 cells
Positive Control Cell lines: C168, MKN45, HT29, A549, Colo205
Subclass IgG1
Myeloma Used P3NSI-Ag-1
Strain Balb/c
Notes Also binds to: granulocytes
Research Area Cancer, Cell Type or Organelle Marker, Epitope Tags

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Durrant et al. 1986. Br J Cancer. 53(1):37-45. PMID: 3947514.

Antigenicity of newly established colorectal carcinoma cell lines.

Europe PMC ID: 3947514


Add a reference

References: 2 entries

Durrant et al. 1986. Br J Cancer. 53(1):37-45. PMID: 3947514.

Antigenicity of newly established colorectal carcinoma cell lines.


Add a reference